How to cite item

Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy

  
@article{APS9801,
	author = {Ze-bo HU and Kun-ling MA and Yang ZHANG and Gui-hua WANG and Liang LIU and Jian LU and Pei-pei CHEN and Chen-chen LU and Bi-cheng LIU},
	title = {Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy},
	journal = {Acta Pharmacologica Sinica},
	volume = {39},
	number = {6},
	year = {2018},
	keywords = {},
	abstract = {Abstract
Inflammation and lipid disorders play crucial roles in synergistically accelerating the progression of diabetic nephropathy (DN). In this study we investigated how inflammation and lipid disorders caused tubulointerstitial injury in DN in vivo and in vitro. Diabetic db/db mice were injected with 10% casein (0.5 mL, sc) every other day for 8 weeks to cause chronic inflammation. Compared with db/db mice, casein-injected db/db mice showed exacerbated tubulointerstitial injury, evidenced by increased secretion of extracellular matrix (ECM) and cholesterol accumulation in tubulointerstitium, which was accompanied by activation of the CXC chemokine ligand 16 (CXCL16) pathway. In the in vitro study, we treated HK-2 cells with IL-1β (5 ng/mL) and high glucose (30 mmol/L). IL-1β treatment increased cholesterol accumulation in HK-2 cells, leading to greatly increased ROS production, ECM protein expression levels, which was accompanied by the upregulated expression levels of proteins in the CXCL16 pathway. In contrast, after CXCL16 in HK-2 cells was knocked down by siRNA, the IL-1β-deteriorated changes were attenuated. In conclusion, inflammation accelerates renal tubulointerstitial lesions in mouse DN via increasing the activity of CXCL16 pathway.},
	url = {http://www.chinaphar.com/article/view/9801}
}